IP Verse

Graf Von Stosch patent opposition analysis

The comprehensive analysis of Graf Von Stosch opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Graf Von Stosch

Stay updated with the latest patent oppositions filed by Graf Von Stosch

Patent NumberTitleApplicantOpposition DateOpposition Company
EP3919048
Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal IrinotecanIPSEN BIOPHARM LTD.Oct 28, 2026LEPTHIEN
EP4512390
Manufacture Of DegarelixFERRING B.V.Oct 28, 2026LEPTHIEN
EP4403579
Formulation For Anti-Alpha4Beta7 AntibodyMILLENNIUM PHARMACEUTICALS, INC.Sep 9, 2026LEPTHIEN
EP3241561
Chimeric Antigen Receptor (Car) With Antigen Binding Domains To The T Cell Receptor Beta Constant RegionAUTOLUS LIMITEDJan 30, 2026KIVIAL
EP3804660
Heart Valve Anchoring DeviceTRICARESSep 11, 2025T HEART
EP4013385
Improved Lipid Nanoparticles For Delivery Of Nucleic AcidsACUITAS THERAPEUTICS, INC.Apr 1, 2025GRAF VON STOSCH
EP3590949
Ribonucleic Acids Containing N1-Methyl-Pseudouracils And Uses ThereofMODERNATX, INC.Feb 17, 2023WITHERS & ROGERS
EP3718565
Respiratory Virus VaccinesMODERNATX, INC.Jan 26, 2023WITHERS & ROGERS
EP2791160
Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNA THERAPEUTICS, INC.Dec 2, 2022WITHERS & ROGERS
EP2922554
Terminally Modified RnaMODERNANov 23, 2022WITHERS & ROGERS

Top clients of Graf Von Stosch

Top companies who are the clients of Graf Von Stosch

CompanyTotal
PIXIUM VISION SA11
WITHERS & ROGERS10
LEPTHIEN3
GRAF VON STOSCH3
TEVA PHARMACEUTICAL INDUSTRIES LTD2
T HEART2
CABINET MALEMONT1
MLLER MEDICAL1
MÖLLER MEDICAL GMBH & CO.KG1
PRU1